GlaxoSmithKline Consumer Healthcare
BSE: 500676 | NSE: GSKCONS | ISIN: INE264A01014 | Food Processing
 |
Nine Months of GlaxoSmithKline Consumer Healthcare |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Sep '05 | Sep '06 | Sep '07 | Sep '08 | Sep '09 | ||||||
|
||||||||||
| Sales Turnover | 724.48 | 847.17 | 993.70 | 1,219.48 | 1,550.63 | |||||
| Other Income | 16.70 | 35.28 | 51.40 | 61.22 | 20.34 | |||||
| Total Income | 741.18 | 882.45 | 1,045.10 | 1,280.70 | 1,570.97 | |||||
| Total Expenses | 578.58 | 690.21 | 808.60 | 1,012.11 | 1,229.40 | |||||
| Operating Profit | 145.90 | 156.96 | 185.10 | 207.37 | 321.23 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 162.60 | 192.24 | 236.50 | 268.59 | 341.57 | |||||
| Interest | 3.29 | 2.67 | 3.40 | 3.94 | 3.36 | |||||
| PBDT | 159.31 | 189.57 | 233.10 | 264.65 | 338.21 | |||||
| Depreciation | 31.18 | 31.83 | 29.20 | 31.29 | 31.64 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 128.13 | 157.74 | 203.90 | 233.36 | 306.57 | |||||
| Tax | 42.39 | 56.13 | 68.80 | 77.61 | 107.47 | |||||
| Net Profit | 85.74 | 101.61 | 135.10 | 155.75 | 199.10 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 20.39 | 24.16 | 32.09 | 37.03 | 47.34 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 42.06 | 42.06 | 42.10 | 42.06 | 42.06 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore GlaxoSmith Con connections | ||||||||||
| ||||||||||
